Induced pluripotent stem cells (iPSCs) have emerged as a transformative tool in the fields of regenerative medicine, drug ...
?? 2024 年 11 月 21 日,北京大学基础医学院血管稳态与重构全国重点实验室的王凯研究员和孔炜教授,与北京大学第三医院临床干细胞研究中心的王茜研究员以及北京大学国际癌症研究院的谢正伟研究员团队合作在 Cell Stem Cell ...
组蛋白赖氨酸甲基转移酶G9a/GLP是T细胞命运的抑制因子,化学抑制G9a/GLP能够诱导人iPSC来源的CAR-T细胞的成熟和持久性,从而 ...
First Patient to Reach 6-Month Follow-up Remains in DORIS Clinical Remission and Free of All Immunosuppressive Therapies SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: ...
Diabetes develops when the body fails to manage its blood glucose levels. One form of diabetes causes the body to not produce ...
Dr. Christopher Seet, an assistant professor of hematology-oncology at the David Geffen School of Medicine at UCLA, has received a $2.9 million R37 MERIT Award from the National Cancer Institute to ...
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, United States ...
Fate Therapeutics (FATE) presented new clinical and translational data from the company’s FT819 Phase 1 Autoimmunity study for ...